Member Exclusive

Gene therapy prevents and reverses corneal blindness in canine model

A collaborative team of researchers has successfully utilized AAV gene therapy for the prevention and reversal of mucopolysaccharidosis type 1 (MPS1) in a canine model.

Go to the profile of RegMedNet
May 02, 2019

Please sign in or register for FREE

No comments yet.